IDT’s Novel rhPCR Unravels Gene Expression

Method enables identification and analysis of highly similar alternatively spliced transcripts

 

CORALVILLE, IA – 09 September 2014 – In DECODED Online, Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, looks at how its novel RNase H2–dependent polymerase chain reaction (rhPCR) method has helped researchers to detect differential amplification of alternatively spliced latrophilin (Lphn) transcripts in mice.

 

Latrophilins are cell adhesion molecules that have been linked with synaptic function, development, and maintenance. The three Lphn genes are very similar, which complicates the use of standard qRT-PCR to distinguish the various transcripts. The rhPCR method developed by IDT overcomes this problem by simultaneously increasing PCR specificity and eliminating primer-dimer formation. This is achieved by using blocked primers, which require cleavage by RNase H2 before they can be used for target amplification. The RNase H2 enzyme is active at standard PCR temperatures and cleaves the 5’ end of a single RNA base in the blocked primer only after the primer hybridizes to its target. Therefore, the primers are unable to form primer-dimers, and with the required high complementarity to their targets, reduce amplification of closely related sequences. The cleaved, unblocked primers are then available for extension and replication.

In DECODED online, IDT discusses a recent publication by Boucard AA et al., which extends the rhPCR method to RT-PCR by the addition of an optimized concentration of RNase H2 after an initial cDNA synthesis step. The method successfully distinguished alternatively spliced variants, allowing Lphn expression to be quantitatively measured in various tissues.

 

The paper represents only one such application of IDT’s innovative rhPCR technology, which also facilitates SNP genotyping, multiplexing, NGS library preparation, and detection of rare alleles. For more information, please visit www.idtdna.com. Follow us on twitter @idtdna for real-time updates and insights.

 

About IDT

Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the world, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides. IDT synthesizes and ships an average of 44,000 custom oligos per day to more than 82,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, California; Leuven, Belgium; and Singapore. For more information, visit www.idtdna.com.

 

Integrated DNA Technologies

800-328-2661 (US & Canada)

+1 319-626-8400 (outside US)

productinfo@idtdna.com

www.idtdna.com